Evaluation of bleeding during nasal surgery. Anticoagulants
Conditions
Interventions
Intervention 1: First intervention group: clonidine 3 micrograms per kilogram will be given orally 90 minutes before the surgery, and the amount of bleeding will be examined during surgery. Interventi
Sponsors
Shoushtar University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Conscious willingness to participate in research Age between 18-60 years Classification of the American Society of Anesthesiology in Class I and II: Class 1: includes patients with normal health who have no systemic problems, such as cardiovascular, respiratory, gastrointestinal, etc. Class 2: Includes a person with mild systemic disease and disease Is under control and has not caused any limitation for the patient)
Exclusion criteria
Exclusion criteria: Drug addiction, benzodiazepines, liver and kidney failure, diabetes, pulmonary and heart disease, coagulation disorders; History of hypersensitivity to clonidine and Tranexamic Acid (increased blood pressure)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of bleeding during nasal surgery. Timepoint: During and after nose surgery. Method of measurement: The size of the bleeding will be calculated based on the amount of bleeding accumulated in the suction and the blood-stained gases that will be weighed and the surgeon's vision. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAkram Hemmatipour
Shoushtar University of Medical Sciences
Outcome results
None listed